Valuation and Qualifying Accounts

12 Months Ended

May 31, 2026

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

VALUATION AND QUALIFYING ACCOUNTS

AngioDynamics, Inc. and Subsidiaries


(in thousands)			SCHEDULE II -VALUATION AND QUALIFYING ACCOUNTS
Description			Balance at Beginning of Year						Additions - Charged to costs and expenses						Deductions						Balance at End of Period
Year Ended May 31, 2024
Allowance for deferred tax asset			$	25,759					$	26,921					$	—					$	52,680
Allowance for sales returns and doubtful accounts			$	2,150					$	1,073					$	(1,082)					$	2,141

Year Ended May 31, 2025
Allowance for deferred tax asset			$	52,680					$	5,760					$	—					$	58,440
Allowance for sales returns and doubtful accounts			$	2,141					$	886					$	(812)					$	2,215

Year Ended May 31, 2026
Allowance for deferred tax asset			$	58,440					$	7,053					$	—					$	65,493
Allowance for sales returns and doubtful accounts			$	2,215					$	385					$	(749)					$	1,851